PHAT: Phathom Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PHAT: Phathom Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 621.55
Enterprise Value ($M) 805.18
Book Value ($M) -187.11
Book Value / Share -2.74
Price / Book -3.32
NCAV ($M) -239.48
NCAV / Share -3.50
Price / NCAV -2.60

Profitability (mra)
Return on Invested Capital (ROIC) -1.02
Return on Assets (ROA) -1.43
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.08
Current Ratio 5.13

Balance Sheet (mrq) ($M)
Current Assets 334.68
Assets 387.04
Liabilities 574.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G BlackRock, Inc. 5.20 0.00
11-04 13G Jennison Associates Llc 10.40
08-22 13D/A Frazier Life Sciences Public Fund, L.P. 18.00 25.75
04-10 13D/A Takeda Pharmaceutical Co Ltd 4.80 -11.50
02-12 13G/A Carlyle Group Inc. 6.10 19.14
02-09 13G/A Invesco Ltd. 5.50 43.49
01-26 13G/A Medicxi Growth I LP 13.00 200.47

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-06-14 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-06-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 659,870 1,969,062 33.51
2024-11-14 378,042 1,335,701 28.30
2024-11-13 446,220 3,237,784 13.78
2024-11-12 989,687 10,195,862 9.71
2024-11-11 423,459 4,140,479 10.23

(click for more detail)

Similar Companies
PCVX – Vaxcyte, Inc. PEPG – PepGen Inc.
PGEN – Precigen, Inc. PHVS – Pharvaris N.V.
PLRX – Pliant Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io